The current position: Home > Jiangsu PL > About PL > Company history
Company history

2006-2014
+
  • 2006
    Changchun ProteLight Pharmaceutical & Biotechnology Co., Ltd. was founded as research and development company.
  • 2009
    Established Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd.(ProteLight Pharma)
  • 2011
    ProteLight Pharma officially acquired Changchun ProteLight as a wholly-owned R&D subsidiary
  • 2012
    The antimicrobial peptide PL-5 spray project was selected into the “12th Five-Year Plan” major new drug innovative manufacture project of the National Health Commission
  • 2014
    Selected as "2014 China's Most Potential Seed Enterprises" by Ernst & Young
2016-2020
+
  • 2016
    The antimicrobial peptide PL-5 spray obtained clinical approval for a new drug, becoming the first innovative antimicrobial peptide drug to enter human clinical trials in China
  • 2017
    Two national category I innovative drugs, the antimicrobial peptide PL-5 spray project and the antimicrobial peptide PL-18 suppository project were selected into the "13th Five-Year Plan" major new drug innovative manufacture projects of the National Health Commission
  • 2019
    ProteLight Pharmaceutical Industry Base forally opens
    Honored as "Potential Unicorn Enterprise of Sunan National Innovation Park "
    Honored as “Wuxin Prospective Unicorn Enterprise”
  • 2020
    Established Nanjing Denovo Pharmaceutical Co., Ltd. (a wholly-owned R&D subsidiary)
    Established Jiangsu Putai Pharmaceutical Technology Co., Ltd.(a wholly-owned subsidiary of disinfection products)
2021-2025
+
  • 2021
    Established ProteLight Medical Holdings (Hong Kong) Co., Ltd. (a wholly-owned subsidiary of overseas business)
 Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd.
 No.1, Anquan Road, Jiangyin
 86-510-86996611